| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 29 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 28 |
| 2 | TACROLIMUS OINTMENT 0.1% | 28 |
| 3 | MYCOPHENOLATE MOFETIL | 27 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 27 |
| 5 | PREDNISOLONE | 13 |
| 6 | PREDNISOLONE ORAL | 13 |
| 7 | PREDNISOLONE ORAL SOLUTION | 13 |
| 8 | METHYLPREDNISOLONE SODIUM SUCCINATE | 9 |
| 9 | OXALIPLATIN | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BELATACEPT | 6 | 0.0013 |
| 1 | SIROLIMUS | 8 | 0.0006 |
| 2 | EVEROLIMUS TABLETS | 7 | 0.0004 |
| 3 | TACROLIMUS OINTMENT 0.1% | 28 | 0.0002 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 28 | 0.0002 |
| 5 | CALCIUM FOLINATE | 1 | 0.0002 |
| 6 | MYCOPHENOLATE MOFETIL | 27 | 0.0002 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 27 | 0.0002 |
| 8 | METHYLPREDNISOLONE SODIUM SUCCINATE | 9 | 0.0002 |
| 9 | TACROLIMUS | 29 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 6 | 0.0013 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 7 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 8 | 0.0000 |
| 6 | Kinase Inhibitor [EPC] | 15 | 0.0000 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 6 | 0.0000 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Aldosterone Antagonist [EPC] | 3 | 0.0000 |